Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial.

Details

Language :

English

ISSN :

01406736

Volume :

379

Issue :

9833

Database :

Academic Search Index

Journal :

Lancet

Publication Type :

Academic Journal

Accession number :

108124401

Full Text :

https://doi.org/10.1016/s0140-6736(12)60479-6